SOPHiA GENETICS SA Net Profit Margin 2020-2025 | SOPH
SOPHiA GENETICS SA net profit margin from 2020 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| SOPHiA GENETICS SA Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-09-30 | $0.07B | $-0.07B | -101.37% |
| 2025-06-30 | $0.07B | $-0.07B | -102.86% |
| 2025-03-31 | $0.07B | $-0.07B | -95.59% |
| 2024-12-31 | $0.07B | $-0.06B | -93.94% |
| 2024-09-30 | $0.07B | $-0.07B | -109.23% |
| 2024-06-30 | $0.07B | $-0.07B | -103.08% |
| 2024-03-31 | $0.06B | $-0.07B | -114.06% |
| 2023-12-31 | $0.06B | $-0.08B | -127.42% |
| 2023-09-30 | $0.06B | $-0.07B | -118.97% |
| 2023-06-30 | $0.05B | $-0.08B | -144.44% |
| 2023-03-31 | $0.05B | $-0.08B | -160.78% |
| 2022-12-31 | $0.05B | $-0.09B | -181.25% |
| 2022-09-30 | $0.05B | $-0.09B | -204.35% |
| 2022-06-30 | $0.04B | $-0.09B | -209.09% |
| 2022-03-31 | $0.04B | $-0.09B | -202.38% |
| 2021-12-31 | $0.04B | $-0.07B | -182.50% |
| 2021-09-30 | $0.04B | $-0.06B | -167.57% |
| 2021-06-30 | $0.03B | $-0.05B | -150.00% |
| 2021-03-31 | $0.03B | $-0.04B | -136.67% |
| 2020-12-31 | $0.03B | $-0.04B | -139.29% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.295B | $0.065B |
| SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.330B | 58.97 |
| Tempus AI (TEM) | United States | $12.432B | 0.00 |
| Doximity (DOCS) | United States | $10.168B | 42.09 |
| Hims & Hers Health (HIMS) | United States | $9.274B | 75.98 |
| IRhythm Technologies (IRTC) | United States | $5.625B | 0.00 |
| Hinge Health (HNGE) | United States | $3.490B | 0.00 |
| Privia Health (PRVA) | United States | $2.876B | 180.23 |
| Heartflow (HTFL) | United States | $2.715B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.376B | 39.32 |
| 10x Genomics (TXG) | United States | $1.898B | 0.00 |
| Enovis (ENOV) | United States | $1.604B | 8.43 |
| Omnicell (OMCL) | United States | $1.601B | 32.73 |
| Clover Health Investments (CLOV) | United States | $1.368B | 0.00 |
| Azenta (AZTA) | United States | $1.346B | 58.74 |
| Phreesia (PHR) | United States | $1.319B | 0.00 |
| Schrodinger (SDGR) | United States | $1.309B | 0.00 |
| Claritev (CTEV) | United States | $1.141B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.807B | 0.00 |
| Evolent Health (EVH) | United States | $0.583B | 0.00 |
| Talkspace (TALK) | United States | $0.571B | 113.67 |
| Butterfly Network (BFLY) | United States | $0.561B | 0.00 |
| Veradigm (MDRX) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.435B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.396B | 0.00 |
| Carlsmed (CARL) | United States | $0.363B | 0.00 |
| TruBridge (TBRG) | United States | $0.292B | 13.39 |
| CapsoVision (CV) | United States | $0.221B | 0.00 |
| Outset Medical (OM) | United States | $0.214B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.212B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.199B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.180B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.179B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.167B | 0.00 |
| CareCloud (CCLD) | United States | $0.147B | 8.06 |
| EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
| Pulmonx (LUNG) | United States | $0.078B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.075B | 0.00 |
| American Well (AMWL) | United States | $0.068B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.040B | 0.00 |
| 111 (YI) | China | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.032B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.026B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |